Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets 
SpaceX Starship Test Flight Reaches New Heights but Ends in Setback 
Jared Isaacman Confirmed as NASA Administrator, Becomes 15th Leader of U.S. Space Agency 
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 
FDA Lifts REMS Requirement for CAR-T Cell Cancer Therapies 
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission 
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now 
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options 
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation 
Tabletop particle accelerator could transform medicine and materials science 
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast 
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions 
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug 
A lot of things in life are thought to be irreversible and menopause has been one of the most devastating for a lot of women. Now, a new treatment that is meant to reverse menopause is about to go on clinical trials.
The trials will be conducted in Athens, Greece, in the Genesis Health Clinic, Futurism reports. It will involve injecting Platelet Rich Plasma into the patients using their own genetic material, which means that there will be fewer complications.
The method has been undergoing preclinical trials for months and has finally been given the green light for next phase. Speaking to New Scientist last year, one of the gynecologists in the facility Konstantinos Sfakianoudis, called the method a way of offering hope to women who still want to become mothers but are no longer able to because of advanced age.
“It offers a window of hope that menopausal women will be able to get pregnant using their own genetic material,” Sfakianoudis said.
The treatment works by basically rejuvenating the ovaries of women who have already undergone menopause. It brings the cells and tissue back to a point where the organs become viable in producing healthy eggs cells that can then be fertilized. Based on the results so far, the method has exhibited a considerable sequence of successful revitalization.
In fact, during preclinical trials, 60 women were provided the treatment and the success rate stood at 75%. This means the return of the capability to conceive both naturally and in vitro fertilization. By the end of it, 9 of the subjects were actually able to get pregnant.
Aside from simply allowing menopausal women to have children again, the treatment can also address many of the effects that come with the transition. This includes alleviating the discomfort brought about by changes in one’s hormones as well generally helping to make women feel young again.
